Oleksandr Brener
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Detecting and Tracking β-Amyloid Oligomeric Forms and Dynamics In Vitro by a High-Sensitivity Fluorescent-Based Assay.
Journal: ACS chemical neuroscience
Published: November 29, 2024
In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 04, 2018
A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Journal: The Journal of biological chemistry
Published: March 23, 2018
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease.
Journal: Molecules (Basel, Switzerland)
Published: September 04, 2017
Increase of Positive Net Charge and Conformational Rigidity Enhances the Efficacy of d-Enantiomeric Peptides Designed to Eliminate Cytotoxic Aβ Species.
Journal: ACS chemical neuroscience
Published: June 01, 2016
Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination.
Journal: PloS one
Published: November 16, 2015
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomers.
Journal: Scientific reports
Published: May 07, 2015
Progress towards structural understanding of infectious sheep PrP-amyloid.
Journal: Prion
Published: December 09, 2014
Last Updated: 09/26/2026